Bortezomib-Associated Severe Orthostatic Hypotension and Hyponatremia
Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 3
Abstract
To the Editor, The most frequent side effects of bortezomib are fatigue, hematologic toxicity with cytopenias, and peripheral neuropathy, whereas postural hypotension and hyponatremia are less common late side effects [1,2]. Hyponatremia is a potentially fatal complication that has been reported in 3%-22% of patients treated with bortezomib, and has been attributed to direct bortezomib toxicity and syndrome of inappropriate anti-diuretic hormone secretion (SIADH) [3]. The direct toxicity of bortezomib might be dose dependent [1]; however; there is insufficient evidence to support this mode of action. We think hyponatremia in the presented patient was due to direct bortezomib toxicity, as it resolved following cessation of bortezomib and saline infusion.
Authors and Affiliations
Elif Suyanı, Zeynep Akı, Gülsan Sucak
Reply: “Auer Rod-Like Inclusions in Reactive Plasma Cells in a Case of Acute Myeloid Leukemia”
.
A Case of Cutaneous Diffuse Large B-cell Lymphoma
About Chediak-Higashi, Hemoglobin Lansing, and Hemoglobin Jabalpur
Ritüksimab İlişkili Geridönüşlü Hepatosellüler Hasar
Co-occurrence of Papillary and Follicular Thyroid Carcinoma in a Patient with Hodgkin’s Disease
To the Editor, Hodgkin’s disease (HD) is a lymphoproliferative neoplasm primarily of B cell origin. The annual incidence of HD is estimated to be 1-3 cases per 100,000 people in the world [1]. Developments in multi-agen...